A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)

NCT00073489 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Astellas Pharma Inc

Collaborators